Summit Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$929K Sell
7,044
-210
-3% -$25.9K 0.33% 88
2023
Q4
$791K Hold
7,254
0.3% 91
2023
Q3
$747K Hold
7,254
0.31% 88
2023
Q2
$837K Hold
7,254
0.33% 85
2023
Q1
$772K Hold
7,254
0.29% 93
2022
Q4
$805K Sell
7,254
-183
-2% -$18.7K 0.32% 90
2022
Q3
$641K Buy
7,437
+117
+2% +$10.4K 0.27% 100
2022
Q2
$668K Hold
7,320
0.26% 101
2022
Q1
$601K Hold
7,320
0.2% 117
2021
Q4
$561K Buy
7,320
+173
+2% +$13.8K 0.18% 122
2021
Q3
$537K Hold
7,147
0.19% 122
2021
Q2
$556K Buy
7,147
+2,052
+40% +$153K 0.21% 115
2021
Q1
$375K Sell
5,095
-68
-1% -$5.02K 0.16% 123
2020
Q4
$403K Buy
5,163
+88
+2% +$6.73K 0.18% 106
2020
Q3
$402K Sell
5,075
-121
-2% -$9.48K 0.2% 101
2020
Q2
$383K Buy
5,196
+293
+6% +$22.1K 0.2% 97
2020
Q1
$360K Buy
4,903
+1,048
+27% +$82.4K 0.21% 93
2019
Q4
$335K Sell
3,855
-120
-3% -$9.86K 0.16% 109
2019
Q3
$319K Sell
3,975
-576
-13% -$46.2K 0.16% 114
2019
Q2
$364K Sell
4,551
-42
-0.9% -$3.22K 0.16% 115
2019
Q1
$365K Hold
4,593
0.29% 82
2018
Q4
$335K Hold
4,593
0.28% 83
2018
Q3
$311K Sell
4,593
-1,960
-30% -$125K 0.23% 90
2018
Q2
$379K Sell
6,553
-13,087
-67% -$738K 0.29% 85
2018
Q1
$1.02M Buy
19,640
+1,619
+9% +$87.4K 0.8% 45
2017
Q4
$968K Sell
18,021
-749
-4% -$41.5K 0.79% 44
2017
Q3
$1.15M Buy
18,770
+944
+5% +$57.2K 0.95% 36
2017
Q2
$1.09M Buy
+17,826
New +$1.09M 0.94% 34

Other funds holding MRK

Summit Financial Group's MRK Position: Q1 2024 in Review

Summit Financial Group reduced its Merck (MRK) stake by 2.9% in Q1 2024, selling an estimated $25.9K and leaving 7,044 shares worth $929K. The position accounts for 0.33% of the portfolio, ranked #88.

Summit Financial Group first reported a position in MRK in Q2 2017 and has held it in 28 quarters since. The position peaked at $1.15M in Q3 2017. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Summit Financial Group held 7,044 shares of Merck worth $929K as of Q1 2024.
  • Summit Financial Group sold 210 Merck shares in Q1 2024, an estimated $25.9K.
  • Merck made up 0.33% of Summit Financial Group's portfolio in Q1 2024, its #88 holding.
  • Summit Financial Group first reported a position in Merck in Q2 2017 and has held it in 28 quarters since.
  • Summit Financial Group's Merck position peaked at $1.15M in Q3 2017.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.